Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-18 17:41 |
CROSSJECT : Résultats semestriels 2020 et point d'activité
|
French | 212.0 KB | ||
| 2020-07-17 12:03 |
Crossject répond à ses actionnaires et aux investisseurs
|
French | 89.9 KB | ||
| 2020-07-01 18:37 |
Crossject : Fin du programme de conversion des OC émises en 2019
|
French | 134.5 KB | ||
| 2020-06-29 18:53 |
Crossject à l'écoute de ses actionnaires et des investisseurs
|
French | 89.5 KB | ||
| 2020-06-29 18:41 |
Crossject : Résultat des votes de l'AG Mixte du 25 juin 2020
|
French | 118.5 KB | ||
| 2020-02-18 18:32 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
English | 57.6 KB | ||
| 2020-01-29 18:06 |
Crossject : Information relative au nombre de droits de vote et d'actions compo…
|
French | 57.5 KB | ||
| 2020-01-10 18:41 |
CROSSJECT : Mise en oeuvre des décisisons votées à l'Assemblée Générale Mixte d…
|
French | 55.1 KB | ||
| 2020-01-07 18:01 |
Crossject : Résultat des votes de l'Assemblée Générale Mixte du 30 décembre 20…
|
French | 93.5 KB | ||
| 2019-12-20 17:55 |
CROSSJECT complète son financement par une émission d'obligations convertibles …
|
French | 86.3 KB | ||
| 2019-12-13 18:47 |
CROSSJECT : Vif succès de l'exercice des BSA
|
French | 100.6 KB | ||
| 2019-12-02 20:32 |
CROSSJECT : Précisions sur le statut de PME européenne
|
French | 59.1 KB | ||
| 2019-11-22 18:37 |
crossject : Convocation des actionnaires à une AGE
|
French | 78.9 KB | ||
| 2019-11-20 18:06 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 92.7 KB | ||
| 2019-11-19 17:44 |
CROSSJECT : Financement structuré de 2,6 M€
|
French | 111.0 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
